PC7. Sindrom Sjögren secundar in colagenoze
Obiectiv. Estimarea incidentei keratoconjunctivitei Sicca in cursul colagenozelor, ca manifestare oculara a sindromului Sjögren secundar.
Material si metoda. Un numar de 17 pacienti, 7 cu L. E. S., 6 cu scleroze sistemice si 4 cu dermatomiozita au fost examinati oftalmologic in scopul evidentierii celor doua semne fundamentale ale xeroftalmiei: reducerea secretiei lacrimale (test Schrimer I) si prezenta keratoconjunctivitei uscate (biomicroscopia directa a polului anterior si dupa instilarea de fluoresceina 1% sau roz bengal 1%).
Rezultate. testul Schrimer I a fost mai putin de 5 mm in 5 minute la 2 pacienti cu L. E. S., una prezentand keratina punctata superficiala, cealalta keratina filamentoasa si la 2 paciente cu S. S. dintre care numai una prezenta keratina punctata superficiala complicata cu ulcer cornneean.
Nu s-au decelat modificari de flux lacrimal in cazurile cu D. M.
Concluzii. Sindromul Sjögren secundar este mai frecvent intalnit in L. E. S. si sclerodermia sistemica si exceptional in D. M.
PC7. Secondary Sjögren Syndrome in Connective Tissue Disease
Objective. To assess the incidence of keratoconjunctivitis Sicca (KCS) associated with connective tissue disease as ocular manifestation of secondary Sjögren Syndrome.
Material and method. A number of 17 patients, 7 with Systemic lupus erythematosus (SLE), 6 with systemic sclerosis (SS) and 4 with dermatomyositis (DM) have been ophtalmological examined with the purpose of showing the two fundamental signs of xerophtalmia: the decreased lacrimal secretion (Schrimer I test) and the presence of KCS (direct slit-lamp biomicroscopy and following instillation of fluorescein 1% or roz bengal 1%).
Results. Schrimer I test less than 5 mm in 5 minutes in 2 patients with SLE (one patient presenting superficial punctate keratitis), the other having filamentary keratitis) and in 2 patients with SS, only one of them presented superficial punctate keratitis) complicated with corneal ulcer it has not been revealed changes of tear flux in patients with DM.
Conclusions. Secondary Sjögren syndrome is more frequently seen in SLE and SS and probably exceptional in DM.